TABLE 1.
Baseline demographics of the studied population.
| PR-NV group (n = 56) | PR-NA group (n = 24) | p-Value | |
| Mean age (years) | 64.5 ± 13.1 | 66.7 ± 12.8 | 0.911 |
| Males | 45 (80.4) | 19 (79.2) | 0.904 |
| Clinical characteristics | |||
| Diabetes | 16 (28.6) | 6 (25.0) | 0.745 |
| Hypertension | 29 (51.8) | 14 (58.3) | 0.593 |
| Hyperlipidemia | 30 (53.6) | 17 (70.8) | 0.153 |
| Current smoking | 19 (33.9) | 5 (20.8) | 0.245 |
| Previous MI | 10 (17.9) | 9 (37.5) | 0.060 |
| Clinical presentation | 0.117 | ||
| STEMI | 29 (51.8) | 17 (70.8) | |
| NSTEMI | 27 (48.2) | 7 (29.2) | |
| Medications at the time of the event | |||
| Anti-platelet therapy | 26 (46.4) | 18 (75.0) | 0.019 |
| Aspirin | 21 (37.5) | 17 (70.8) | 0.006 |
| P2Y12 inhibitor | 5 (8.9) | 5 (20.8) | 0.157 |
| Statins | 27 (48.2) | 19 (79.2) | 0.010 |
| ACEI/ARB | 24 (42.9) | 15 (62.5) | 0.144 |
| β-Blockers | 19 (33.9) | 14 (58.3) | 0.051 |
| Culprit vessel | 0.896 | ||
| LAD | 29 (51.8) | 14 (58.3) | |
| LCx | 12 (21.4) | 3 (12.5) | |
| RCA | 15 (26.8) | 7 (29.2) | |
Values are presented as n (%) or mean ± SD. MI, myocardial infarction; STEMI, ST-segment elevation myocardial infarction; NSTEMI, non-ST-segment elevation myocardial infarction; ACEI, angiotensin converting enzyme inhibitors; ARB, angiotensin receptor blocker; LAD, left anterior descending; LCx, left circumflex artery; RCA, right coronary artery. The values in bold type indicate that they are statistically significantly with p-value of <0.05.